Fold-change consistency between EdgeR and DESeq2 methods. A) Correlation analysis between fold-change obtained by both methods. The figure shows a tight linear trend between EdgeR and DESeq2 fold-change estimations. Genes found significant for both methods are represented in yellow circles, in green and red are genes significantly differentially expressed by one of the two methods and in white, genes with no significant changes by both techniques. B) Bland Altman analysis comparing the mean fold-changes of both methods (x-axis) and the difference between them (y-axis). This plot allows the identification of any systematic difference between methods and possible outliers. Each circle represents an HSP gene and their colours the subtype for w...
Clinical trial BR9601 information. (a) Schematic representation. (b) Patient information. Figure S2....
Differential gene expression pattern analysis for dermal comparisons identified by RNA sequencing. (...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...
HSPs differential gene expression between tumour tissues. The values were determined by EdgeR ANOVA-...
Differential gene expression in BRCA TCGA tumours. Summary of EdgeR ANOVA-like differential gene exp...
Summary of HSP subfamily Fold Change trends across PAM50 subtypes. Boxplot representing HSP subfamil...
HSP clusters characterization. A) Centroid of HSP clusters expression profiles for TCGA, METABRIC tr...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Dendrogram analysis of hierarchical clustering based on HSPs gene expression. The separation distanc...
Quantitative PCR analysis of various genes involved in different signaling cascades in breast cancer...
Protein-coding genes associated with HER2 amplification. (A) List of 43 protein-coding genes with su...
Data analysis workflow. Schematic representation of HSPs transcriptomic and survival analysis proces...
PAM50 classification quality control of TCGA’s samples I. A) Principal components analysis of the tr...
Figure S4. Unsupervised clustering of histone modification occupancy in highly variable regions (A, ...
PAM50 classification quality control of TCGA’s samples II. Unsupervised hierarchical clustering of s...
Clinical trial BR9601 information. (a) Schematic representation. (b) Patient information. Figure S2....
Differential gene expression pattern analysis for dermal comparisons identified by RNA sequencing. (...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...
HSPs differential gene expression between tumour tissues. The values were determined by EdgeR ANOVA-...
Differential gene expression in BRCA TCGA tumours. Summary of EdgeR ANOVA-like differential gene exp...
Summary of HSP subfamily Fold Change trends across PAM50 subtypes. Boxplot representing HSP subfamil...
HSP clusters characterization. A) Centroid of HSP clusters expression profiles for TCGA, METABRIC tr...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Dendrogram analysis of hierarchical clustering based on HSPs gene expression. The separation distanc...
Quantitative PCR analysis of various genes involved in different signaling cascades in breast cancer...
Protein-coding genes associated with HER2 amplification. (A) List of 43 protein-coding genes with su...
Data analysis workflow. Schematic representation of HSPs transcriptomic and survival analysis proces...
PAM50 classification quality control of TCGA’s samples I. A) Principal components analysis of the tr...
Figure S4. Unsupervised clustering of histone modification occupancy in highly variable regions (A, ...
PAM50 classification quality control of TCGA’s samples II. Unsupervised hierarchical clustering of s...
Clinical trial BR9601 information. (a) Schematic representation. (b) Patient information. Figure S2....
Differential gene expression pattern analysis for dermal comparisons identified by RNA sequencing. (...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...